SALIVACLEAR
Live / Registered — Registered (as of 16 Aug 2022)
What this means for you
Registered since 16 Aug 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 16 Aug 2028: the §8 declaration of use).
Record
- Serial number
- 90286249
- Registration number
- 6821965
- Mark type
- Word mark
- Filed
- 29 Oct 2020
- Published for opposition
- 11 May 2021
- Registered
- 16 Aug 2022
- Next maintenance filing
- §8 declaration of use, due by 16 Aug 2028 (grace period to 16 Feb 2029)
- Attorney of record
- Kimberly I. Shimomura
Goods and services
- Class 010 — Medical apparatus: Direct-to-consumer test kits containing medical instruments for taking samples for review for various medical conditions; medical diagnostic testing kits containing sterile medical specimen collection tools in the nature of saliva collection tubes and vials for the collection of saliva for use in testing various medical conditions, and also including instructions and return shipping packaging
- Class 044 — Medical, beauty and agricultural services: Medical testing of saliva; medical testing for diagnostic or treatment purposes in the field of illnesses
Owner
- Mirimus, Inc., Brooklyn, NY, US
- Mirimus, Inc., Brooklyn, NY, US
- Mirimus, Inc., Brooklyn, NY, US
Prosecution history
- 16 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 15 Jul 2022 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 14 Jul 2022 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 27 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 27 Jun 2022 — ASSIGNED TO LIE
- 14 Jun 2022 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 19 Feb 2022 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 19 Feb 2022 — NON-FINAL ACTION E-MAILED
- 19 Feb 2022 — SU - NON-FINAL ACTION - WRITTEN
- 24 Jan 2022 — STATEMENT OF USE PROCESSING COMPLETE
- 06 Jan 2022 — USE AMENDMENT FILED
- 24 Jan 2022 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 06 Jan 2022 — TEAS STATEMENT OF USE RECEIVED